Taconic Capital Advisors’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-193,351
Closed -$37.3K – 79
2025
Q2
$37.3K Sell
193,351
-103,773
-35% -$19.7K ﹤0.01% 52
2025
Q1
$55.3K Sell
297,124
-65,876
-18% -$15.9K ﹤0.01% 45
2024
Q4
$87.2K Hold
363,000
– – 0.01% 40
2024
Q3
$54.5K Hold
363,000
– – ﹤0.01% 36
2024
Q2
$25.4K Hold
363,000
– – ﹤0.01% 47
2024
Q1
$12.7K Hold
363,000
– – ﹤0.01% 72
2023
Q4
$10.2K Hold
363,000
– – ﹤0.01% 103
2023
Q3
$18.6K Hold
363,000
– – ﹤0.01% 112
2023
Q2
$17.2K Hold
363,000
– – ﹤0.01% 161
2023
Q1
$21.8K Hold
363,000
– – ﹤0.01% 203
2022
Q4
$20K Buy
+363,000
New +$16.8K ﹤0.01% 382

Other funds holding SBCWW

Taconic Capital Advisors's SBCWW Position: Q3 2025 in Review

Taconic Capital Advisors sold out of SBC Medical Group Warrants (SBCWW) in Q3 2025, closing a stake of 193,351 shares — an estimated $37.3K sold.

Taconic Capital Advisors first reported a position in SBCWW in Q4 2022 and held it in 11 quarters. The position peaked at $87.2K in Q4 2024. 17 funds tracked by Wall St. Rank hold SBCWW as of Q3 2025.

  • Taconic Capital Advisors reported no remaining SBC Medical Group Warrants position as of Q3 2025 after selling out during the quarter.
  • Taconic Capital Advisors sold 193,351 SBC Medical Group Warrants shares in Q3 2025, an estimated $37.3K.
  • Taconic Capital Advisors first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 11 quarters.
  • Taconic Capital Advisors's SBC Medical Group Warrants position peaked at $87.2K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q3 2025.

Based on Taconic Capital Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.